Tesamorelin recalls

The FDA has published 2 recalls involving Tesamorelin since 2018. The latest was reported on 15 Oct 2025. GenoGenix has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2018

Last 12 months1reported

Class I00% of total

Ongoing1latest 15 Oct 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 1 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why tesamorelin is recalled

Other Reasons150%
Sterility150%

Companies

GenoGenix150%
Tailor Made Compounding150%

By year

2025150%
2018150%

Ongoing tesamorelin recalls

1 active

Reported	Class	Recall	Company	Reason	Where
15 Oct 2025Drug	CLASS II	Tesamorelin for Injection, 15mg Multi-Dose Vial, GenoGenix recalled	GenoGenix	Sterility	Nationwide

All tesamorelin recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
15 Oct 2025Drug	CLASS II	Tesamorelin for Injection, 15mg Multi-Dose Vial, GenoGenix recalled	GenoGenix	Sterility	Nationwide
14 Nov 2018Drug	CLASS II	Tesamorelin, 1mg/vial, Lyophilized Powder recalled	Tailor Made Compounding	Other	Nationwide

Should you stop taking Tesamorelin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.